barclaysplc-novemberbatch
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
December
01, 2023
Barclays PLC
(Name
of Registrant)
1 Churchill Place
London E14 5HP
England
(Address
of Principal Executive Office)
Indicate
by check mark whether the registrant files or will file annual
reports
under
cover of Form 20-F or Form 40-F.
Form
20-F x Form 40-F
This
Report on Form 6-K is filed by Barclays PLC.
This
Report comprises:
Information
given to The London Stock Exchange and furnished pursuant
to
General
Instruction B to the General Instructions to Form 6-K.
EXHIBIT
INDEX
FOR BATCHES:
Exhibit
No. 1
|
Total Voting Rights dated 01 November 2023
|
Exhibit
No. 2
|
Publication
of Final Terms dated 06 November 2023
|
Exhibit
No. 3
|
Director/PDMR
Shareholding dated 08 November 2023
|
Exhibit
No. 4
|
Publication
of Supplementary Prospectus dated 22 November 2023
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
BARCLAYS
PLC
|
|
(Registrant)
|
Date:
December 01, 2023
|
By: /s/
Garth Wright
--------------------------------
|
|
Garth
Wright
|
|
Assistant
Secretary
|
Exhibit
No. 1
1 November 2023
Barclays PLC
Total Voting Rights
In accordance with the Financial Conduct Authority's (FCA)
Disclosure Guidance and Transparency Rule 5.6.1R, Barclays PLC
notifies the market that as of 31 October 2023, Barclays PLC's
issued share capital consists of 15,074,170,544 Ordinary shares
with voting rights.
There are no Ordinary shares held in Treasury.
The above figure 15,074,170,544 may be used by shareholders (and
others with notification obligations) as the denominator for the
calculation by which they will determine if they are required to
notify their interest in, or a change to their interest in,
Barclays PLC under the FCA's Disclosure Guidance and Transparency
Rules.
- Ends
-
For further information, please contact:
Investor Relations
Marina Shchukina
+44 (0)20 7116 2526
|
|
Media Relations
Jon Tracey
+44 (0)20 7116 4755
|
Exhibit No. 2
Publication of Final Terms
The following final terms (the "Final Terms") are available for viewing:
Final Terms in relation to Barclays PLC's issue of GBP
1,000,000,000 7.090 per cent. Fixed Rate Resetting Senior Callable
Notes due 6 November 2029, issued under the Barclays PLC Debt
Issuance Programme.
Please read the disclaimer below "Disclaimer - Intended
Addressees" before attempting
to access this service, as your right to do so is conditional upon
complying with the requirements set out below.
To view the full document, please paste the following URL into the
address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/5408S_1-2023-11-6.pdf
A copy of the Final Terms has been submitted to the National
Storage Mechanism and will shortly be available for inspection
at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism
For further information, please contact:
Barclays Treasury
1 Churchill Place
Canary Wharf
London E14 5HP
DISCLAIMER - INTENDED ADDRESSEES
IMPORTANT: You must read the following
before continuing: The
following applies to the Final Terms available by clicking on the
link above, and you are therefore advised to read this carefully
before reading, accessing or making any other use of the Final
Terms. In accessing the Final Terms, you agree to be bound by the
following terms and conditions, including any modifications to
them, any time you receive any information from us as a result of
such access.
The Final Terms referred to above must be read in conjunction with
the base prospectus dated 7 March 2023 (as supplemented by the
prospectus supplements dated 28 April 2023, 28 July 2023 and 25
October 2023) which together constitute a base prospectus (the
"Prospectus") for the purposes of Regulation (EU) 2017/1129,
as it forms part of domestic law of the United Kingdom by virtue of
the European Union (Withdrawal) Act 2018, as amended (the
"UK
Prospectus Regulation").
THE FINAL TERMS MAY NOT BE FORWARDED OR DISTRIBUTED OTHER THAN AS
PROVIDED BELOW AND MAY NOT BE REPRODUCED IN ANY MANNER WHATSOEVER.
THE FINAL TERMS MAY ONLY BE DISTRIBUTED OUTSIDE THE UNITED STATES
TO PERSONS THAT ARE NOT U.S. PERSONS AS DEFINED IN, AND IN RELIANCE
ON, REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED
(THE "SECURITIES
ACT"). ANY FORWARDING,
DISTRIBUTION OR REPRODUCTION OF THE FINAL TERMS IN WHOLE OR IN PART
IS PROHIBITED. FAILURE TO COMPLY WITH THIS NOTICE MAY RESULT IN A
VIOLATION OF THE SECURITIES ACT OR THE APPLICABLE LAWS OF OTHER
JURISDICTIONS.
NOTHING IN THIS ELECTRONIC PUBLICATION CONSTITUTES AN OFFER OF
SECURITIES FOR SALE IN ANY JURISDICTION. ANY NOTES ISSUED OR TO BE
ISSUED PURSUANT TO THE FINAL TERMS AND THE PROSPECTUS HAVE NOT
BEEN, AND WILL NOT BE, REGISTERED UNDER THE SECURITIES ACT OR THE
SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR OTHER
JURISDICTION. ANY NOTES ISSUED OR TO BE ISSUED PURSUANT TO THE
FINAL TERMS AND THE PROSPECTUS MAY NOT BE OFFERED, SOLD, PLEDGED OR
OTHERWISE TRANSFERRED EXCEPT IN AN OFFSHORE TRANSACTION TO A PERSON
THAT IS NOT A U.S. PERSON IN ACCORDANCE WITH RULE 903 OR RULE 904
OF REGULATION S UNDER THE SECURITIES ACT.
Please note that the information contained in the Final Terms and
the Prospectus referred to above may be addressed to and/or
targeted at persons who are residents of particular countries
(specified in the Final Terms and/or the Prospectus) only and is
not intended for use and should not be relied upon by any person
outside these countries and/or to whom the offer contained in the
Final Terms and/or the Prospectus is not
addressed. Prior to relying on the
information contained in the Final Terms and/or the Prospectus you
must ascertain from the Final Terms and the Prospectus whether or
not you are part of the intended addressees of the information
contained therein.
Confirmation of your Representation: In order to be eligible to view the Final Terms
or make an investment decision with respect to any Notes issued or
to be issued pursuant to the Final Terms, you must be a person
other than a U.S. person (within the meaning of Regulation S under
the Securities Act). By accessing the Final Terms, you shall be
deemed to have represented that you and any customers you represent
are not U.S. persons, and that you consent to delivery of the Final
Terms via electronic publication.
You are reminded that the Final Terms has been made available to
you on the basis that you are a person into whose possession the
Final Terms may be lawfully delivered in accordance with the laws
of the jurisdiction in which you are located and you may not, nor
are you authorised to, deliver the Final Terms to any other
person.
The Final Terms does not constitute, and may not be used in
connection with, an offer or solicitation in any place where offers
or solicitations are not permitted by law. If a jurisdiction
requires that the offering be made by a licensed broker or dealer
and the underwriters or any affiliate of the underwriters is a
licensed broker or dealer in that jurisdiction, the offering shall
be deemed to be made by the underwriters or such affiliate on
behalf of the issuer in such jurisdiction. Under no
circumstances shall the Final Terms constitute an offer to
sell, or the solicitation of an offer to buy, nor shall there be
any sale of any Notes issued or to be issued pursuant to the
Final Terms, in any jurisdiction in which such offer,
solicitation or sale would be unlawful.
The Final Terms have been made available to you in an electronic
form. You are reminded that documents transmitted via this medium
may be altered or changed during the process of electronic
transmission and consequently none of the issuer, its advisers nor
any person who controls any of them nor any director, officer,
employee nor agent of it or affiliate of any such person accepts
any liability or responsibility whatsoever in respect of any
difference between the Final Terms made available to you in
electronic format and the hard copy version available to you on
request from the issuer.
Your right to access this service is conditional upon complying
with the above requirement.
Exhibit
No. 3
08 November 2023
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
a)
|
Name
|
Paul Compton
|
2
|
Reason for the notification
|
a)
|
Position/status
|
Global Head of Corporate & Investment Bank, and President,
Barclays Bank Plc
|
b)
|
Initial notification /Amendment
|
Initial notification
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
a)
|
Name
|
Barclays PLC
|
b)
|
LEI
|
213800LBQA1Y9L22JB70
|
4.1
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
a)
|
Description of the financial instrument, type of
instrument
Identification code
|
Ordinary shares with a nominal value of 25 pence each
("Shares")
GB0031348658
|
b)
|
Nature of the transaction
|
Disposal of Shares by Solium Capital UK Limited in its capacity as
administrator of the Barclays' nominee service.
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s):
Number of Shares sold
|
£1.3615 per Share
|
93,797
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
Not applicable
|
e)
|
Date of the transaction
|
2023-11-07
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
For further information please contact:
Investor Relations Media
Relations
Marina Shchukina +44 (0) 20 7116 2526 Jonathan
Tracey +44 (0) 20 7116 4755
Exhibit
No. 4
Publication of Prospectus Supplement
The following prospectus supplement (the "Prospectus
Supplement") is available
for viewing:
Prospectus Supplement dated 15 November 2023 in connection with
Barclays PLC's issue of $1,750,000,000 9.625% Fixed Rate Resetting
Perpetual Subordinated Contingent Convertible Securities
(the "Securities") incorporating the Prospectus dated 1 March 2021
relating to the Securities (the "Base
Prospectus").
Please read the disclaimer below "Disclaimer - Intended
Addressees" before attempting to access this service, as your right
to do so is conditional upon complying with the requirements set
out below.
To view the Prospectus Supplement, please paste the following URL
into the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/3846U_1-2023-11-22.pdf
A copy of the above documents have been submitted to the National
Storage Mechanism and will shortly be available for inspection
at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
For further information, please contact:
Barclays Treasury
1 Churchill Place
Canary Wharf
London E14 5HP
DISCLAIMER - INTENDED ADDRESSEES
IMPORTANT: You must read the following before
continuing: The following
applies to the Prospectus Supplement available by clicking on the
link above, and you are therefore advised to read this carefully
before reading, accessing or making any other use of the Prospectus
Supplement. In accessing the Prospectus Supplement, you agree to be
bound by the following terms and conditions, including any
modifications to them, any time you receive any information from us
as a result of such access.
The Prospectus Supplement referred to above must be read in
conjunction with the Base Prospectus.
THE PROSPECTUS SUPPLEMENT MAY NOT BE FORWARDED OR DISTRIBUTED OTHER
THAN AS PROVIDED BELOW AND MAY NOT BE REPRODUCED IN ANY MANNER
WHATSOEVER. ANY FORWARDING, DISTRIBUTION OR REPRODUCTION OF THE
PROSPECTUS SUPPLEMENT IN WHOLE OR IN PART IS PROHIBITED. FAILURE TO
COMPLY WITH THIS NOTICE MAY RESULT IN A VIOLATION OF THE
U.S. SECURITIES ACT OF 1933, AS AMENDED, OR THE APPLICABLE
LAWS OF OTHER JURISDICTIONS.
NOTHING IN THIS ELECTRONIC PUBLICATION CONSTITUTES AN OFFER OF
SECURITIES FOR SALE IN ANY JURISDICTION. ANY SECURITIES ISSUED OR
TO BE ISSUED PURSUANT TO THE PROSPECTUS SUPPLEMENT HAVE NOT BEEN
AND WILL NOT BE REGISTERED UNDER THE SECURITIES LAWS OF ANY
JURISDICTION OTHER THAN THE UNITED STATES.
Please note that the information contained in the Prospectus
Supplement and the Base Prospectus referred to above may be
addressed to and/or targeted at persons who are residents of
particular countries (specified in the Prospectus Supplement and
the Base Prospectus) only and is not intended for use and should
not be relied upon by any person outside these countries and/or to
whom the offer contained in the Prospectus Supplement and/or the
Base Prospectus is not addressed. Prior to relying on the
information contained in the Prospectus Supplement and/or the
Base Prospectus you must ascertain from the Prospectus Supplement
and the Base Prospectus whether or not you are part of the intended
addressees of the information contained
therein.
You are reminded that the Prospectus Supplement has been made
available to you on the basis that you are a person into whose
possession the Prospectus Supplement may be lawfully delivered in
accordance with the laws of the jurisdiction in which you are
located and you may not, nor are you authorised to, deliver the
Prospectus Supplement to any other person.
The Prospectus Supplement does not constitute, and may not be used
in connection with, an offer or solicitation in any place where
offers or solicitations are not permitted by law. If a jurisdiction
requires that the offering be made by a licensed broker or dealer
and the underwriters or any affiliate of the underwriters is a
licensed broker or dealer in that jurisdiction, the offering shall
be deemed to be made by the underwriters or such affiliate on
behalf of the issuer in such jurisdiction. Under no
circumstances shall the Prospectus Supplement constitute an offer
to sell, or the solicitation of an offer to buy, nor shall there be
any sale of any Securities issued or to be issued pursuant to
the Prospectus Supplement, in any jurisdiction in which such
offer, solicitation or sale would be unlawful.
The Prospectus Supplement has been made available to you in an
electronic form. You are reminded that documents transmitted via
this medium may be altered or changed during the process of
electronic transmission and consequently none of the issuer, its
advisers nor any person who controls any of them nor any director,
officer, employee nor agent of it or affiliate of any such person
accepts any liability or responsibility whatsoever in respect of
any difference between the Prospectus Supplement made available to
you in electronic format and the hard copy versions available to
you on request from the issuer.
Your right to access this service is conditional upon complying
with the above requirement.